| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | President &CEO | President and CEO
1 company
Marucci Anthony S serves as a President &CEO at CLDX. Across recent SEC filings that breaks down to 3 buys and 1 sell. Those positions are worth an estimated $1.1M at current prices.
The biggest single holding is CLDX (~$1.1M) as President &CEO. The recent filings there lean toward selling, a net 87,700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | CLDX Celldex Therapeutics, Inc. | President &CEO | Buy | 11,500 | $26.82 | $308,430.00 | +40.0% | -17.9% | -7.0% | |
| Aug 15, 2022 | CLDX Celldex Therapeutics, Inc. | President &CEO | Sale+OE | 120,000 | $37.66 | $4,519,572.00 | -81.3% | -2.8% | -16.3% | |
| Jun 9, 2020 | CLDX Celldex Therapeutics, Inc. | President &CEO | Buy | 15,000 | $3.06 | $45,900.00 | +338.0% | - | - | |
| Aug 13, 2015 | CLDX Celldex Therapeutics, Inc. | President and CEO | Buy | 5,800 | $16.81 | $97,497.42 | +13.1% | - | - |